|
業務類別
|
Biotechnology |
|
業務概覽
|
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. |
| 公司地址
| 8 Moore Drive, Durham, NC, USA, 27713 |
| 電話號碼
| +1 877 495-0816 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.fortrea.com |
| 員工數量
| 14300 |
| Mr. David R. Smith |
Director and Interim Chief Financial Officer |
-- |
29/07/2026 |
| Mr. Robert A. Parks |
Chief Accounting Officer |
-- |
14/07/2026 |
| Mr. Anshul Thakral |
Director, President and Chief Executive Officer |
美元 401.92K |
27/04/2026 |
| Mr. Mark A. Morais |
Chief Operating Officer and President, Clinical Services |
美元 506.58K |
27/04/2026 |
| Mr. Jason F. Knoblauch |
Chief Financial Officer |
-- |
29/07/2026 |
| Mr. Carrie Russell |
Vice President, Accounting |
-- |
14/07/2026 |
|
|
| Mr. Peter M. Neupert |
Chairman of the Board |
27/04/2026 |
| Mr. Edward A. Pesicka |
Independent Director |
27/04/2026 |
| Mr. William J. Sharbaugh |
Director |
27/04/2026 |
| Ms. Erin L. Russell |
Independent Director |
27/04/2026 |
| Mr. David R. Smith |
Director and Interim Chief Financial Officer |
29/07/2026 |
| Mr. Anshul Thakral |
Director, President and Chief Executive Officer |
27/04/2026 |
| Ms. A. Machelle Sanders |
Independent Director |
27/04/2026 |
| Dr. Amrit Ray, M.B.A.,M.D. |
Independent Director |
27/04/2026 |
|
|
|
|
